Evaluation of the blood coagulation mechanism and platelet aggregation in individuals with mechanical or biological heart prostheses

Blood Coagulation and Fibrinolysis

Volumn 13, Issue 2, 2002, Pages 129-134

  Ferreira, C N ^a   Vieira, L M ^a   Dusse, L M S ^a   Reis, C V ^a   Amaral, C F S ^a   Esteves, W A M ^a   Fenelon, L M A ^a   Carvalho, Maria Graças ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Heart prostheses; Hypercoagulability; Warfarin

Indexed keywords

BLOOD CLOTTING FACTOR; PROTEIN C; PROTEIN S; VITAMIN K GROUP; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BLOOD CLOTTING INHIBITOR; WARFARIN;

ACCURACY; ADULT; ANTICOAGULANT THERAPY; ARTICLE; BIOLOGICAL MONITORING; BLOOD CLOTTING; CONTROLLED STUDY; EVALUATION; FEMALE; HEART VALVE PROSTHESIS; HUMAN; HYPERCOAGULABILITY; MALE; PRIORITY JOURNAL; REGULATORY MECHANISM; RISK FACTOR; THROMBOCYTE AGGREGATION; ADOLESCENT; AGED; ANALYSIS OF VARIANCE; BLOOD CLOTTING TEST; CASE CONTROL STUDY; COMPARATIVE STUDY; DRUG EFFECT; DRUG SCREENING; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTICOAGULANTS; ASPIRIN; BLOOD COAGULATION; BLOOD COAGULATION FACTOR INHIBITORS; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; DRUG EVALUATION; FEMALE; HEART VALVE PROSTHESIS; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; WARFARIN;

EID: 0036489856     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200203000-00008     Document Type: Article

References (14)

1. Hereditary protein S deficiency and venous thromboembolism: A study in three Dutch families
2. Relationship between protein C antigen and anticoagulant activity during oral anticoagulation in selected disease states
3. Does warfarin enhance platelet activity?
4. The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients
5. Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin
6. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses
7. Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: A meta-analysis
8. Combined warfarin and antiplatelet therapy after St. Jude medical valve replacement for mitral valve disease
9. Comparison of high-dose with low-dose aspirin in patients with mechanical heart valve replacement treated with oral anticoagulant
10. Problems of oral anticoagulation in an adult with homozygous protein C deficiency and late onset of thrombosis
11. Randomized prospective trial comparing the native prothrombin antigen with the prothrombin time for monitoring oral anticoagulant therapy
12. Comparison of plasma prothrombin and factor VII and urine prothrombin F1 concentrations in patients on long-term warfarin therapy and those in the initial phase
13. Plasma levels of factors II, VII and X and their relationship to the international normalized ratio during chronic warfarin therapy
14. Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy